Araştırma Makalesi

The Role of Vitamin B12 and Folate in Habitual Abortion

Cilt: 6 Sayı: 3 5 Eylül 2021
PDF İndir
TR EN

The Role of Vitamin B12 and Folate in Habitual Abortion

Abstract

Objective: Although several pathophysiological mechanisms are defined in the etiology of habitual abortion, still causes half of the cases haven’t been clarified yet. It has been reported that folate and vitamin B12 are effective in early pregnancy complications. In our study, we aimed to reveal the relationship between habitual abortion with folate and vitamin B12 levels.
Materials and Methods: We included our study 124 pregnant having habitual abortion history and 242 pregnants without this, a total of 366 patients. Maternal and gestational age, height, weight, body mass index (BMI), gravidity, parity, abortion, and living children count and vitamin B12 and folate levels of these pregnants were evaluated retrospectively.
Results: The ages, gravidity, and abortion counts of the study group were significantly higher than the control group (p<0.05). While the weight, height measurements, vitamin B12, and folate measurements showed no significant difference (p>0.05) between groups, the BMI measurements, living children count, and of the study group were significantly lower than the control group (p<0.05). 
Conclusion: According to our results, we didn’t find any relationship between habitual abortion with folate and vitamin B12 levels. Further larger sample-sized and prospective studies are required to contribute to the literature about this issue. 

Keywords

Kaynakça

  1. Von Eye Corleta H. It is time to respect the American Society for Reproductive Medicine definition of recurrent pregnancy loss. Fertil Steril. 2010;94(4):e61. doi:10.1016/j.fertnstert. 2010.06.020
  2. Regan L, Backos M, Rai R. Royal College of Obstetricians & Gynaecologists. The investigation and treatment of couples with recurrent first-trimester and second trimester miscarriage. Guideline No. 17, 2011. https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_17.pdf. Accessed November 8, 2020.
  3. Fritz M, Goldberg J, McClure RD et al. The Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. 2012. https://www.fertstert.org/action/showPdf?pii=S0015-0282%2812%2900701-7. Accessed November 8,2020.
  4. Silver RM, Branch DW, Goldenberg R, Iams JD, Klebanoff MA. Nomenclature for pregnancy outcomes Time for a change. American Collage of Obsterics and Gynecology. 2011;118(6):1402-1408. doi:10.1097/AOG.0b013e3182392977
  5. Pei C, Kim YJ, Baek K. Pathogenetic factors involved in recurrent pregnancy loss from multiple aspects. Obstet Gynecol. 2019;62(4):212-223. doi:10.5468/ogs.2019.62.4.212
  6. Solé-Navais P, Cavallé-Busquets P, Fernandez-Ballart JD, Murphy MM. Early pregnancy B vitamin status, one carbon metabolism, pregnancy outcome and child development. Biochimie. 2016;126:91-96. doi:10.1016/j.biochi.2015.12.003
  7. Yang T, Gu Y, Wei X et al. Periconceptional folic acid supplementation and vitamin B 12 status in a cohort of Chinese early pregnancy women with the risk of adverse pregnancy outcomes. J Clin Biochem Nutr. 2017;60(2):136-142. doi:10.3164/jcbn.16-45
  8. Sukumar N, Rafnsson SB, Kandala N, Bhopal R, Yajnik CS, Saravanan P. Prevalence of vitamin B-12 insufficiency during pregnancy and its effect on offspring birth weight : a systematic review and meta analysis. Am J Clin Nutr. 2016;103:1232-1251. doi:10.3945/ajcn.115.123083

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

5 Eylül 2021

Gönderilme Tarihi

8 Kasım 2020

Kabul Tarihi

3 Haziran 2021

Yayımlandığı Sayı

Yıl 2021 Cilt: 6 Sayı: 3

Kaynak Göster

AMA
1.Yılmaz Z, Güvey H, Çelik S, vd. The Role of Vitamin B12 and Folate in Habitual Abortion. OTSBD. 2021;6(3):347-352. doi:10.26453/otjhs.822978

Creative Commons Lisansı
 

Online Türk Sağlık Bilimleri Dergisi Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı ile lisanslanmıştır.

Bu, Creative Commons Atıf Lisansı (CC BY-NC 4.0) şartları altında dağıtılan açık erişimli bir dergidir. Orijinal yazar(lar) veya lisans verenin adı ve bu dergideki orijinal yayının kabul görmüş akademik uygulamaya uygun olarak atıfta bulunulması koşuluyla, diğer forumlarda kullanılması, dağıtılması veya çoğaltılmasına izin verilir. Bu şartlara uymayan hiçbir kullanım, dağıtım veya çoğaltmaya izin verilmez.

Makale gönderme süreçleri ve "Telif Hakkı Devir Formu" hakkında yardım almak için tıklayınız.